Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology
Geoffrey C. Nguyen(Johns Hopkins Medicine), Clive Kearon(McMaster University), John K. Marshall(McMaster University), Alain Bitton(McGill University Health Centre), William Geerts(University of Toronto), Marc Carrier(University of Ottawa), Grigorios I. Leontiadis(McMaster University), Brian Bressler(University of British Columbia), Nilesh Chande(Western University), Anne M. Griffiths(University of Toronto), Anthony K.C. Chan(McMaster Children's Hospital), Chadwick Williams, J. Decker Butzner(University of Calgary), Çharles N. Bernstein(University of Manitoba)
Cited by 349
Related Papers
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
|Journal of Thrombosis and Haemostasis|2005|4.9k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k